Post-transplant lymphoproliferative disorder, early lesion (Q39453): Difference between revisions

From determinar.ia.br - Determine suas informações
Created a new Item
 
Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
Distúrbio linfoproliferativo que surge como resultado da terapia de imunossupressão pós-transplante. É caracterizada pela ausência de destruição e pela preservação arquitetônica dos tecidos envolvidos. Inclui duas variantes morfológicas: hiperplasia plasmocítica e doenças linfoproliferativas semelhantes à mononucleose infecciosa.
description / endescription / en
 
A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.

Revision as of 04:52, 13 August 2026

A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.
Language Label Description Also known as
default for all languages
2B32.0
    English
    Post-transplant lymphoproliferative disorder, early lesion
    A lymphoproliferative disorder arising as a result of post-transplant immunosuppression therapy. It is characterised by the lack of tissue destruction and the architectural preservation of the involved tissues. It includes two morphologic variants: plasmacytic hyperplasia and infectious mononucleosis-like lymphoproliferative disorders.

      Statements